Publications

Click on underlined titles to be transferred to PubMed. Not all titles are linked to PubMed.

Chou S, Marousek G, Bowlin TL.

(2012). Cyclopropavir susceptibility of cytomegalovirus DNA polymerase mutants selected after antiviral drug exposure. Antimicrobial Agents and Chemotherapy. Jan;56(1):197-201. PMCID: PMC3256009.

 

Williams JD, Khan AR, Harden EA, Hartline CB, Jefferson GM, Keith KA, Prichard MN, Zemlicka J, Peet NP, Bowlin TL.

(2012). Synthesis and antiviral activity of certain second generation methylenecyclopropane nucleosides. Bioorg Med Chem. Jun 15;20(12):3710-8. PMID: 22607883.

 

James, S.H., Hartline, C.B., Harden, E.A., Driebe, E., Schupp, J., Engelthaler, D., Bowlin, T.L., Kern, E.R., Prichard, M.N.

(2011) Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase. Antimicrobial Agents and Chemotherapy. Oct;55(10):4682-91. Epub 2011 Jul 25. PMID: 21788463.

 

Chou S., Bowlin T.L.

(2010) Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility. Antimicrob Agents Chemother. Jan;55(1):382-4. PMCID: PMC3019618.

 

Aiello D., Williams J. D., Majgier-Baranowska H., Patel I., Peet N. P., Huang J., Lory S., Bowlin T. L., Moir D. T.

(2010) Discovery and Characterization of Inhibitors of Pseudomonas aeruginosa Type III Secretion. Antimicrob Agents and Chemother. 54(5): 1988-99. PMCID: PMC2863679.

 

Wu, Z., J.C. Drach, M.N. Prichard, M. Yanachkova, I. Yanachkov, T.L., Bowlin, and J. Zemlicka.

(2009) L-Valine ester of cyclopropavir: a new antiviral prodrug. Antiviral Chem. & Chemother. 20: 37-46. PMID: 19794230.